Should patients manage their own oral anticoagulation therapy?

Oral anticoagulant therapy has become more commonly prescribed for people of 65 years and over following the widening of its clinical indications to include thromboembolic prophylaxis in atrial fibrillation. It is estimated that approximately 470 000 people in the UK, almost 1% of the population, ar...

Full description

Saved in:
Bibliographic Details
Published in:Reviews in clinical gerontology 2002-11, Vol.12 (4), p.275-281
Main Authors: Marzonlini, M, Wynne, Hilary
Format: Article
Language:English
Subjects:
Cost control
Drug therapy
Editorial
Family physicians
Health services
Sample size
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Oral anticoagulant therapy has become more commonly prescribed for people of 65 years and over following the widening of its clinical indications to include thromboembolic prophylaxis in atrial fibrillation. It is estimated that approximately 470 000 people in the UK, almost 1% of the population, are currently receiving oral anticoagulant therapy and this is growing. Due to its narrow therapeutic index, and the intra-individual variation in dose requirement, there is a need to monitor the level of anticoagulation in each patient. In consequence, health systems have had to invest resources into monitoring services to cope with this development.
ISSN:0959-2598
1469-9036
DOI:10.1017/S0959259802012418